AdaptHealth Statistics
Total Valuation
AdaptHealth has a market cap or net worth of $1.09 billion. The enterprise value is $3.10 billion.
| Market Cap | 1.09B |
| Enterprise Value | 3.10B |
Important Dates
The next confirmed earnings date is Tuesday, May 6, 2025, before market open.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AdaptHealth has 134.87 million shares outstanding. The number of shares has increased by 0.83% in one year.
| Current Share Class | 134.87M |
| Shares Outstanding | 134.87M |
| Shares Change (YoY) | +0.83% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 11.24% |
| Owned by Institutions (%) | 75.85% |
| Float | 87.56M |
Valuation Ratios
The trailing PE ratio is 13.21 and the forward PE ratio is 7.34. AdaptHealth's PEG ratio is 1.01.
| PE Ratio | 13.21 |
| Forward PE | 7.34 |
| PS Ratio | 0.33 |
| Forward PS | 0.32 |
| PB Ratio | 0.67 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 4.59 |
| P/OCF Ratio | 2.00 |
| PEG Ratio | 1.01 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.62, with an EV/FCF ratio of 13.15.
| EV / Earnings | 37.47 |
| EV / Sales | 0.95 |
| EV / EBITDA | 4.62 |
| EV / EBIT | 10.15 |
| EV / FCF | 13.15 |
Financial Position
The company has a current ratio of 1.33, with a Debt / Equity ratio of 1.35.
| Current Ratio | 1.33 |
| Quick Ratio | 0.92 |
| Debt / Equity | 1.35 |
| Debt / EBITDA | 2.88 |
| Debt / FCF | 9.04 |
| Interest Coverage | 2.41 |
Financial Efficiency
Return on equity (ROE) is 6.23% and return on invested capital (ROIC) is 5.11%.
| Return on Equity (ROE) | 6.23% |
| Return on Assets (ROA) | 4.25% |
| Return on Invested Capital (ROIC) | 5.11% |
| Return on Capital Employed (ROCE) | 7.79% |
| Revenue Per Employee | $310,569 |
| Profits Per Employee | $7,881 |
| Employee Count | 10,500 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 19.82 |
Taxes
In the past 12 months, AdaptHealth has paid $41.24 million in taxes.
| Income Tax | 41.24M |
| Effective Tax Rate | 30.32% |
Stock Price Statistics
The stock price has decreased by -17.84% in the last 52 weeks. The beta is 1.45, so AdaptHealth's price volatility has been higher than the market average.
| Beta (5Y) | 1.45 |
| 52-Week Price Change | -17.84% |
| 50-Day Moving Average | 9.60 |
| 200-Day Moving Average | 10.17 |
| Relative Strength Index (RSI) | 37.68 |
| Average Volume (20 Days) | 1,514,266 |
Short Selling Information
The latest short interest is 8.42 million, so 6.24% of the outstanding shares have been sold short.
| Short Interest | 8.42M |
| Short Previous Month | 9.59M |
| Short % of Shares Out | 6.24% |
| Short % of Float | 9.62% |
| Short Ratio (days to cover) | 4.60 |
Income Statement
In the last 12 months, AdaptHealth had revenue of $3.26 billion and earned $82.75 million in profits. Earnings per share was $0.61.
| Revenue | 3.26B |
| Gross Profit | 749.16M |
| Operating Income | 305.51M |
| Pretax Income | -730.11M |
| Net Income | 82.75M |
| EBITDA | 670.84M |
| EBIT | 305.51M |
| Earnings Per Share (EPS) | $0.61 |
Balance Sheet
The company has $112.65 million in cash and $2.13 billion in debt, giving a net cash position of -$2.02 billion or -$14.96 per share.
| Cash & Cash Equivalents | 112.65M |
| Total Debt | 2.13B |
| Net Cash | -2.02B |
| Net Cash Per Share | -$14.96 |
| Equity (Book Value) | 1.58B |
| Book Value Per Share | 11.93 |
| Working Capital | 188.80M |
Cash Flow
In the last 12 months, operating cash flow was $541.84 million and capital expenditures -$306.06 million, giving a free cash flow of $235.78 million.
| Operating Cash Flow | 541.84M |
| Capital Expenditures | -306.06M |
| Free Cash Flow | 235.78M |
| FCF Per Share | $1.75 |
Margins
Gross margin is 22.97%, with operating and profit margins of 9.37% and 2.77%.
| Gross Margin | 22.97% |
| Operating Margin | 9.37% |
| Pretax Margin | 4.17% |
| Profit Margin | 2.77% |
| EBITDA Margin | 20.57% |
| EBIT Margin | 9.37% |
| FCF Margin | 7.23% |
Dividends & Yields
AdaptHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.83% |
| Shareholder Yield | -0.83% |
| Earnings Yield | 7.64% |
| FCF Yield | 21.77% |
Analyst Forecast
The average price target for AdaptHealth is $13.80, which is 71.22% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.80 |
| Price Target Difference | 71.22% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | 26.27% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AdaptHealth has an Altman Z-Score of 1.09 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.09 |
| Piotroski F-Score | 8 |